They are not intended for human consumption, veterinary use, self-administration, clinical use, treatment, diagnosis, prevention, cosmetic use, supplement use, body composition use or any form of personal use
Endotoxins and non-alcoholic fatty liver disease
What the Research Shows Clinical trials have consistently shown liver benefits from GLP-1 medications in patients with fatty liver disease
A recent study poses this modified version (3) of the Harvard Healthy Eating Plate as a guide for GLP-1 diets that may help get you started (10): Your diet should be sustainable, which may mean that you shouldnt be overly strict with yourself
Agonists stimulate receptors to produce an action, while antagonists block or inhibit the action of agonists
Importantly, none of the trials in T1D reported an increase in diabetic ketoacidosis (DKA) a key concern that has limited the use of SGLT2 inhibitors in T1D